Skip to main content
. 2025 Dec 23;5(1):1. doi: 10.3390/muscles5010001
AGEs Advanced Glycation End-products
BMI Body Mass Index
CI Confidence Interval
CMIE Continuous Moderate-Intensity Exercise
CRP C-Reactive Protein
CVD Cardiovascular Disease
GLUT4 Glucose Transporter Type 4
HDL-c High-Density Lipoprotein Cholesterol
HIIT High-Intensity Interval Training
HIIE High-Intensity Interval Exercise
HRmax Maximum Heart Rate
IL-6 Interleukin-6
IL-10 Interleukin-10
MICT Moderate-Intensity Continuous Training
NAFLD Non-Alcoholic Fatty Liver Disease
NF-κB Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells
NPY Neuropeptide Y
PI3K/Akt Phosphoinositide 3-Kinase/Protein Kinase B
PTX3 Pentraxin-3
RCT Randomized Controlled Trial
RM Repetition Maximum
T2D Type 2 Diabetes
TLR2/4 Toll-Like Receptor 2/4
TNF-α Tumor Necrosis Factor-Alpha
VO2max Maximal Oxygen Uptake
Wmax Maximum Workload